Naumann R, Felber W, Heilemann H, Reuster T
Lancet. 1999 Aug 14;354(9178):566-7. doi: 10.1016/S0140-6736(99)03111-6.
The antipsychotic drug olanzapine was developed to reduce the risk of haematotoxicity. We report a case of agranulocytosis induced by olanzapine.
